Kovoor J G, Tivey D R, Ovenden C D, Babidge W J, Maddern G J
University of Adelaide, Adelaide, South Australia, Australia.
Australian Safety and Efficacy Register of New Interventional Procedures-Surgical, Royal Australasian College of Surgeons, Adelaide, South Australia, Australia.
BJS Open. 2021 Jul 6;5(4). doi: 10.1093/bjsopen/zrab048.
Coronavirus (COVID-19) forced surgical evolution worldwide. The extent to which national evidence-based recommendations, produced by the current authors early in 2020, remain valid, is unclear. To inform global surgical management and a model for rapid clinical change, this study aimed to characterize surgical evolution following COVID-19 through a multifaceted systematic review.
Rapid reviews were conducted targeting intraoperative safety, personal protective equipment and triage, alongside a conventional systematic review identifying evidence-based guidance for surgical management. Targeted searches of PubMed and Embase from 31 December 2019 were repeated weekly until 7 August 2020, and systematic searches repeated monthly until 30 June 2020. Literature was stratified using Evans' hierarchy of evidence. Narrative data were analysed for consistency with earlier recommendations. The systematic review rated quality using the AGREE II and AMSTAR tools, was registered with PROSPERO, CRD42020205845. Meta-analysis was not conducted.
From 174 targeted searches and six systematic searches, 1256 studies were identified for the rapid reviews and 21 for the conventional systematic review. Of studies within the rapid reviews, 903 (71.9 per cent) had lower-quality design, with 402 (32.0 per cent) being opinion-based. Quality of studies in the systematic review ranged from low to moderate. Consistency with recommendations made previously by the present authors was observed despite 1017 relevant subsequent publications.
The evidence-based recommendations produced early in 2020 remained valid despite many subsequent publications. Weaker studies predominated and few guidelines were evidence-based. Extracted clinical solutions were globally implementable. An evidence-based model for rapid clinical change is provided that may benefit surgical management during this pandemic and future times of urgency.
冠状病毒病(COVID-19)促使全球外科领域发生变革。目前的作者在2020年初制定的基于国家证据的建议在多大程度上仍然有效尚不清楚。为了为全球外科管理提供信息并建立快速临床变革模型,本研究旨在通过多方面的系统评价来描述COVID-19后的外科变革。
针对术中安全性、个人防护装备和分诊进行快速评价,同时进行传统的系统评价以确定外科管理的循证指南。从2019年12月31日起每周重复对PubMed和Embase进行定向检索,直至2020年8月7日,每月重复系统检索直至2020年6月30日。文献根据埃文斯证据等级进行分层。分析叙述性数据与早期建议的一致性。系统评价使用AGREE II和AMSTAR工具对质量进行评分,已在PROSPERO注册,注册号为CRD42020205845。未进行荟萃分析。
通过174次定向检索和6次系统检索,确定了1256项用于快速评价的研究和21项用于传统系统评价的研究。在快速评价的研究中,903项(71.9%)设计质量较低,402项(32.0%)基于观点。系统评价中的研究质量从低到中等不等。尽管随后有1017篇相关出版物,但仍观察到与本作者先前提出的建议一致。
尽管随后有许多出版物,但2020年初制定的循证建议仍然有效。较弱的研究占主导地位,很少有指南基于证据。提取的临床解决方案可在全球实施。提供了一个基于证据的快速临床变革模型,这可能有助于在本次大流行及未来紧急情况下的外科管理。